These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 26951083)
1. Gene of the month: Axl. Brown M; Black JR; Sharma R; Stebbing J; Pinato DJ J Clin Pathol; 2016 May; 69(5):391-7. PubMed ID: 26951083 [TBL] [Abstract][Full Text] [Related]
2. Apoptotic Bodies Elicit Gas6-Mediated Migration of AXL-Expressing Tumor Cells. Zweemer AJM; French CB; Mesfin J; Gordonov S; Meyer AS; Lauffenburger DA Mol Cancer Res; 2017 Dec; 15(12):1656-1666. PubMed ID: 28923840 [TBL] [Abstract][Full Text] [Related]
3. Axl as a mediator of cellular growth and survival. Axelrod H; Pienta KJ Oncotarget; 2014 Oct; 5(19):8818-52. PubMed ID: 25344858 [TBL] [Abstract][Full Text] [Related]
4. AXL regulates mesothelioma proliferation and invasiveness. Ou WB; Corson JM; Flynn DL; Lu WP; Wise SC; Bueno R; Sugarbaker DJ; Fletcher JA Oncogene; 2011 Apr; 30(14):1643-52. PubMed ID: 21132014 [TBL] [Abstract][Full Text] [Related]
5. AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications. Zhu C; Wei Y; Wei X Mol Cancer; 2019 Nov; 18(1):153. PubMed ID: 31684958 [TBL] [Abstract][Full Text] [Related]
6. Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells. Al Kafri N; Hafizi S Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32664510 [TBL] [Abstract][Full Text] [Related]
7. AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network. Abu-Thuraia A; Goyette MA; Boulais J; Delliaux C; Apcher C; Schott C; Chidiac R; Bagci H; Thibault MP; Davidson D; Ferron M; Veillette A; Daly RJ; Gingras AC; Gratton JP; Côté JF Nat Commun; 2020 Jul; 11(1):3586. PubMed ID: 32681075 [TBL] [Abstract][Full Text] [Related]
8. Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival. Ammoun S; Provenzano L; Zhou L; Barczyk M; Evans K; Hilton DA; Hafizi S; Hanemann CO Oncogene; 2014 Jan; 33(3):336-46. PubMed ID: 23318455 [TBL] [Abstract][Full Text] [Related]
9. Skipping of exon 10 in Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414 [TBL] [Abstract][Full Text] [Related]
10. Combined inhibition of AXL, Lyn and p130Cas kinases block migration of triple negative breast cancer cells. Pénzes K; Baumann C; Szabadkai I; Orfi L; Kéri G; Ullrich A; Torka R Cancer Biol Ther; 2014; 15(11):1571-82. PubMed ID: 25482942 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA H19 regulates HIF-1α/AXL signaling through inhibiting miR-20b-5p in endometrial cancer. Zhu H; Jin YM; Lyu XM; Fan LM; Wu F Cell Cycle; 2019 Oct; 18(19):2454-2464. PubMed ID: 31411527 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer. Tanaka M; Siemann DW Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576116 [TBL] [Abstract][Full Text] [Related]
13. Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis. Kirane A; Ludwig KF; Sorrelle N; Haaland G; Sandal T; Ranaweera R; Toombs JE; Wang M; Dineen SP; Micklem D; Dellinger MT; Lorens JB; Brekken RA Cancer Res; 2015 Sep; 75(18):3699-705. PubMed ID: 26206560 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of Axl in non-MYCN amplified neuroblastoma cell lines reduces migration. Duijkers FA; Meijerink JP; Pieters R; van Noesel MM Gene; 2013 May; 521(1):62-8. PubMed ID: 23523856 [TBL] [Abstract][Full Text] [Related]
15. The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion. Zdżalik-Bielecka D; Poświata A; Kozik K; Jastrzębski K; Schink KO; Brewińska-Olchowik M; Piwocka K; Stenmark H; Miączyńska M Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244439 [TBL] [Abstract][Full Text] [Related]
16. Role of the receptor tyrosine kinase Axl in hepatocellular carcinoma and its clinical relevance. Niu ZS; Niu XJ; Wang WH Future Oncol; 2019 Feb; 15(6):653-662. PubMed ID: 30648886 [TBL] [Abstract][Full Text] [Related]
17. Oxidative stress enhances Axl-mediated cell migration through an Akt1/Rac1-dependent mechanism. Huang JS; Cho CY; Hong CC; Yan MD; Hsieh MC; Lay JD; Lai GM; Cheng AL; Chuang SE Free Radic Biol Med; 2013 Dec; 65():1246-1256. PubMed ID: 24064382 [TBL] [Abstract][Full Text] [Related]
18. TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma. Ruicci KM; Meens J; Plantinga P; Stecho W; Pinto N; Yoo J; Fung K; MacNeil D; Mymryk JS; Barrett JW; Howlett CJ; Boutros PC; Ailles L; Nichols AC J Exp Clin Cancer Res; 2020 Oct; 39(1):217. PubMed ID: 33059733 [TBL] [Abstract][Full Text] [Related]
19. AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis. Choi YJ; Kim JH; Rho JK; Kim JS; Choi CM; Kim WS; Son J; Lee JC Oncol Rep; 2017 Apr; 37(4):2201-2208. PubMed ID: 28260071 [TBL] [Abstract][Full Text] [Related]
20. Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma. Dantas-Barbosa C; Lesluyes T; Loarer FL; Chibon F; Treilleux I; Coindre JM; Meeus P; Brahmi M; Bally O; Ray-Coquard I; Sunyach MP; Cesne AL; Mir O; Bonvalot S; Toulmonde M; Italiano A; Saintigny P; Jean-Denis M; Ducimetiere F; Ranchere D; El Sayadi H; Alberti L; Blay JY Br J Cancer; 2017 Dec; 117(12):1787-1797. PubMed ID: 29024938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]